Totale mesorektale Exzision (TME): Macht sie die Strahlentherapie überflüssig?

Literatur

• 1 Dt. Krebsgesellschaft .Kurzgefasste Interdisziplinäre Leitlinien, Rektumkarzinom. 3. Auflage. München, Bern, Wien, New York: W. Zuckerschwerdt 2002: 179
• 2 Heald R J, Husband E M, Ryall R DH. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence?.  Br J Surg. 1982;  69 613-616
• 3 Kapiteijn E, Marijnen C AM, Nagtegaal I D. et al . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med. 2001;  345 638-648
• 4 Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas.  Int J Colorectal Dis. 2001;  16 298-304
• 5 Porter A G, Soskolne C L, Yakimets W W. et al . Surgeon-related factors and outcome in rectal cancer.  Ann Surg. 1998;  227 157-267
• 6 Quirke P, Durdey P, Dixon N F, Williams N S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision.  Lancet. 1986;  336 996-998
• 7 Rödel C, Sauer R. Perioperative Radiotherapy and concurrent radiochemotherapy in rectal cancer.  Semin Surg Oncol. 2001;  20 3-12
• 8 Sauer R, Fietkau R, Wittekind C. et al . Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: a progress report of a phase-III randomized trial.  Strahlenther Onkol. 2001;  177 173-81
• 9 Wolmark N, Wieand H S, Hyams D M. et al . Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.  J Natl Cancer Inst. 2000;  92 388-396